
Xiuqiong Chen
Articles
-
Aug 5, 2024 |
mdpi.com | Yanan Bu |Xiuqiong Chen |Ting Wu |Ruolin Zhang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 17, 2024 |
mdpi.com | Xiuqiong Chen |Ting Wu |Yanan Bu |Huiqiong Yan
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 13, 2024 |
nature.com | Xiuqiong Chen
AbstractElevated infiltration of tumor-associated macrophages (TAMs) drives tumor progression and correlates with poor prognosis for various tumor types. Our research identifies that the ablation of the Pim-1 proto-oncogene (PIM1) in non-small cell lung cancer (NSCLC) suppresses TAM infiltration and prevents them from polarizing toward the M2 phenotype, thereby reshaping the tumor immune microenvironment (TME).
-
Sep 19, 2023 |
mdpi.com | Hongcai Wang |Xiuqiong Chen |Ting Wu |Ruhong Yin
Article Menu/ajax/scifeed/subscribeAltmetricannouncementHelpformat_quoteCitethumb_up... EndorseNeed Help? Find support for a specific problem in the support section of our website. Please let us know what you think of our products and services. Visit our dedicated information section to learn more about MDPI.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →